New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Automated, accurate reporting for NGS-based clonality testing

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot
Oncology January 23,2024
Automated, accurate reporting for NGS-based clonality testing

Automated, accurate reporting for NGS-based clonality testing

by Impact Journals LLCPolyclonal, Clonal and Restricted Repertoire Phenotypes in Clonality Testing. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28429A new research paper titled &quot
Oncology January 23,2024
Specialized immune cells carry potential for new cancer immunotherapies

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442
Oncology January 23,2024
Specialized immune cells carry potential for new cancer immunotherapies

Specialized immune cells carry potential for new cancer immunotherapies

byLeiden UniversityTumor-infiltrating Vδ1 and Vδ3 T cell subsets display hallmarks of cytotoxic activity in MMR-d colon cancers. a, UMAP embedding showing the clustering of γδ T cells (n = 4,442
Oncology January 23,2024
Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

byUniversity of Rhode IslandCredit: Unsplash/CC0 Public DomainResearchers from the University of Rhode Island and Yale University have demonstrated a promising new approach to delivering immunot
Oncology January 23,2024
Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

byUniversity of Rhode IslandCredit: Unsplash/CC0 Public DomainResearchers from the University of Rhode Island and Yale University have demonstrated a promising new approach to delivering immunot
Oncology January 23,2024
Having more babies lowers the risk of endometrial cancer, study finds

Having more babies lowers the risk of endometrial cancer, study finds

by Institute for Molecular BioscienceCredit: Unsplash/CC0 Public DomainUniversity of Queensland research has revealed that having more babies reduces a woman's risk of endometrial cancer.Dr. Gunn-
Oncology January 23,2024
Having more babies lowers the risk of endometrial cancer, study finds

Having more babies lowers the risk of endometrial cancer, study finds

by Institute for Molecular BioscienceCredit: Unsplash/CC0 Public DomainUniversity of Queensland research has revealed that having more babies reduces a woman's risk of endometrial cancer.Dr. Gunn-
Oncology January 23,2024
Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

byBrigham and Women’s HospitalCredit: Unsplash/CC0 Public DomainBrigham researchers and international collaborators identified the association with younger age and advanced stage at diagnosis, c
Oncology January 23,2024
Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

byBrigham and Women’s HospitalCredit: Unsplash/CC0 Public DomainBrigham researchers and international collaborators identified the association with younger age and advanced stage at diagnosis, c
Oncology January 23,2024
Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi
Oncology January 23,2024
Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi
Oncology January 23,2024
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
Oncology January 23,2024
Study finds cancer cells use a new fuel in absence of sugar

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ
Oncology January 23,2024
Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas
Oncology January 23,2024
Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

Enzyme inhibition promotes bone formation and curbs the development of bone metastases, study finds

byGerman Cancer Research CenterNegative regulation of bone formation by TAM receptor MERTK.amRNA expression analysis of TAM receptor familyMertk,Tyro3,Axl,Gas
Oncology January 23,2024
Cell fate choice during adult regeneration is highly disorganized, study finds

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,
Oncology January 23,2024
Cell fate choice during adult regeneration is highly disorganized, study finds

Cell fate choice during adult regeneration is highly disorganized, study finds

by Nicole Davis,Whitehead Institute for Biomedical ResearchMERFISH labeling of major tissue classes in a thin sagittal section. Cartoon represents spatial location of depicted region. Scale bar,
Oncology January 23,2024
Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be
Oncology January 23,2024
Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be
Oncology January 23,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com